Taiwan Liposome Company

Taiwan Liposome Company is a company listed under the stock ticker 7TLA (TW).

View the org chart displaying its 17 main executives

Most searched biographies at Taiwan Liposome Company

• Keelung Hong, Founder, Chairman and Chief Executive Officer
• Chan Lee, Director
• Beatrice Liu, Director

Create your alert
to follow the executive moves at Taiwan Liposome Company.

Taiwan Liposome Company has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Taiwan Liposome Company

• TLC Announces Early Completion of Patient Enrollment in TLC590 Phase II Clinical Trial following Bunionectomy-TLC
• TLC Reports Fiscal Year End 2019 Financial Results and Provides Business Update-TLC
• TLC Announces Dosing of First Patients in Part 2 of TLC590 Phase II Trial for Postsurgical Pain following Bunionectomy-TLC
• TLC to Present at Berenberg Pain Seminar -TLC
• TLC Announces Completion of US$27 Million Financing-TLC
• TLC Reports Third Quarter 2019 Financial Results and Provides Business Update-TLC
• TLC Presents Clinical and Preclinical Data of TLC590 at ANESTHESIOLOGY® Annual Meeting and in International Journal of Nanomedicine-TLC
• TLC Appoints Vincent Chang, PhD, as Vice President of Manufacturing Development-TLC
• TLC to Present Potential Cartilage-Protecting Effects of TLC599 on the Knee at 2019 ACR Annual Meeting-TLC
• TLC Announces Initiation of Phase III Pivotal Clinical Trial of TLC599 for the Treatment of Osteoarthritis Knee Pain-TLC
• View more press releases Close

Social media about Taiwan Liposome Company

• Taiwan Liposome Company on Wikipedia, Google News & Yahoo Finance
• Taiwan Liposome Company on LinkedIn, Twitter & YouTube

Contact by email its executives including Carina Chen

Call Taiwan Liposome Company at +886 22...

View the org chart

Register to receive your alert

Report an error